#biosimilars #Sandoz #businessstrategy #pharmanews #Bio100 #biologics #patentprotection #patientaccess #RichardSaymor #ShanghaiHenliusBiotech #genericmedicines #generics #biosimilarpipeline #biosimilardevelopment #biologicmedicines #smallmoleculemedicines
pharmaphorum.com/news/sandoz-...